In early childhood, a woman developed multiple red papules on the nose and cheeks with the appearance of angiofibromas (see Figure 1). As an adult, papules formed around her toes which were consistent ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved topical Hyftor for the treatment of facial angiofibroma in patients who have tuberous sclerosis ...

Tuberous sclerosis complex (TSC) is a genetic condition that leads to the development of benign tumors in multiple organs, including the brain, eyes, heart, kidneys, skin, and lungs. This condition ...

The Company plans to discontinue further clinical development of ganaxolone in TSC. Marinus Pharmaceuticals announced that its phase 3 trial of ganaxolone did not meet the primary end point for the ...

Tuberous sclerosis complex (TSC) is a rare genetic condition that causes non-cancerous (benign) tumors in various organs of the body, including in the brain. It is also accompanied by patches of ...

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...